NCT00184717View on ClinicalTrials.gov

Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)

PHASE3CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 18, 2004

Primary Completion Date

March 29, 2006

Study Completion Date

December 28, 2009

Conditions
Foetal Growth ProblemSmall for Gestational Age
Interventions
DRUG

somatropin

0.033 mg/kg/day of NN-220 for s.c. injection in cartridge

DRUG

somatropin

0.067 mg/kg/day of NN-220 for s.c. injection in cartridge

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY